Ping An Biomedical (NASDAQ: PASW) switches auditors from WWC to Edston
Rhea-AI Filing Summary
Ping An Biomedical Co., Ltd. reported a change in its independent auditors. On August 5, 2026, the board resolved not to reappoint WWC, P.C. as independent accountants, ending a relationship that began with the year ended September 30, 2020. WWC’s reports for the fiscal years ended September 30, 2024 and 2025 contained no adverse opinions or qualifications, and the company reports no disagreements or reportable events during WWC’s engagement.
The board approved the appointment of Edston Global PAC as the new independent registered public accounting firm, effective August 6, 2026. The company states it did not consult Edston on accounting principles, audit opinions, or any disagreements before this appointment. WWC’s confirming letter to the SEC, dated August 7, 2026, is included as an exhibit.
Positive
- None.
Negative
- None.
Key Figures
Board decision date on former auditor: August 5, 2026
New auditor effective date: August 6, 2026
WWC tenure start period: year ended September 30, 2020
+2 more
5 metrics
Board decision date on former auditor
August 5, 2026
Board resolved not to reappoint WWC, P.C. as independent accountants, effective that date.
New auditor effective date
August 6, 2026
Edston Global PAC engaged as independent registered public accounting firm from this date.
WWC tenure start period
year ended September 30, 2020
WWC, P.C. has rendered reports on consolidated financial statements since this reporting year.
Fiscal years with no adverse opinion
September 30, 2024 and 2025
WWC provided no adverse opinions or qualifications on these fiscal year financial statements.
WWC letter date
August 7, 2026
WWC’s letter to the SEC is dated this day and attached as Exhibit 16.1.
Key Terms
independent registered public accounting firm, reportable events, Item 16F(a)(1)(v) of Form 20-F, foreign private issuer, +1 more
5 terms
independent registered public accounting firm regulatory
"We have engaged Edston Global PAC as our independent registered public accounting firm..."
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
reportable events regulatory
"None of the reportable events described under Item 16F(a)(1)(v) of Form 20-F occurred..."
Reportable events are significant incidents or changes a company is legally required to disclose to regulators and the public, such as major safety problems, legal actions, financial irregularities, or management changes. They matter to investors because these events can alter a company’s risk profile or future performance, much like a dashboard warning light signals a problem that could affect a car’s safety or reliability. Timely disclosure helps investors make informed decisions and maintain market fairness.
Item 16F(a)(1)(v) of Form 20-F regulatory
"None of the reportable events described under Item 16F(a)(1)(v) of Form 20-F occurred..."
foreign private issuer regulatory
"Form 6-K report of foreign private issuer pursuant to Rule 13a-16..."
A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.
Form 20-F regulatory
"whether the registrant files or will file annual reports under cover Form 20-F..."
Form 20-F is the standardized annual disclosure that non-U.S. companies must file with the U.S. securities regulator when their shares are traded in the U.S.; it contains audited financial statements, a plain-language description of the business, management discussion, governance details and key risk factors. It matters to investors because it provides a consistent, comparable company “report card” and rulebook, helping buyers assess financial health, governance and risks before investing.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What auditor change did Ping An Biomedical (PASW) report?
Ping An Biomedical reported that its board decided on August 5, 2026 not to reappoint WWC, P.C. as independent accountants and instead engaged Edston Global PAC as its new independent registered public accounting firm, effective August 6, 2026.
Were there any disagreements with WWC, P.C. for Ping An Biomedical (PASW)?
The company states that during the fiscal years ended September 30, 2024 and 2025, and through this filing date, WWC had no disagreements with Ping An Biomedical on accounting principles, financial statement disclosure, or audit scope, and no reportable events occurred under Item 16F(a)(1)(v) of Form 20-F.
How long had WWC, P.C. served as Ping An Biomedical’s (PASW) auditor?
WWC, P.C. had rendered reports on Ping An Biomedical’s consolidated financial statements since the year ended September 30, 2020. The change therefore ends a multi-year auditor relationship covering several reporting periods, including the fiscal years ended September 30, 2024 and 2025.
When did Edston Global PAC become Ping An Biomedical’s (PASW) new auditor?
Edston Global PAC was engaged as Ping An Biomedical’s independent registered public accounting firm effective August 6, 2026. The company notes that this engagement followed board approval and that it had not previously consulted Edston on accounting principles or potential audit opinions.
Did Ping An Biomedical (PASW) consult Edston before appointing it auditor?
Ping An Biomedical states it had not consulted Edston during the two most recent fiscal years and up to this report on applying accounting principles, expected audit opinions, or any disagreement matters that would influence its accounting or financial reporting decisions.
What document from WWC, P.C. did Ping An Biomedical (PASW) include with this filing?
The company included as Exhibit 16.1 a letter from WWC, P.C. dated August 7, 2026 and addressed to the SEC. WWC was provided a copy of the report and its letter is incorporated by reference into the submission.